Ordinary Adjustment | Solactive Global Healthcare Exposure Index | Effective Date 7th November 2024
Solactive Global Healthcare Exposure Index:
In the ordinary adjustment, the following composition will be implemented effective open 7th November 2024:
| ESSITY AB CLASS B |
| JOHNSON & JOHNSON |
| NOVARTIS AG |
| MEDTRONIC PLC |
| PROCTER & GAMBLE CO |
| VENTURE CORPORATION LIMITED |
| ABBVIE INC |
| MEDIBANK PRIVATE |
| GSK PLC |
| SONIC HEALTHCARE (TECH AUST) ORD |
| MEIJI HOLDINGS CO LTD |
| ROCHE HOLDING AG |
| ONO PHARMACEUTICAL CO LTD ORD |
| VENTAS INC |
| ROYALTY PHARMA PLC- CL A |
| TAKEDA PHARMACEUTICAL |
| GILEAD SCIENCES INC |
| ORION OYJ CLASS B |
| AMGEN INC |
| PFIZER INC |
| HIKMA PHARMACEUTICALS PLC |
| COLOPLAST AS CLASS B |
| MERCK & CO. INC. |
| SANOFI SA |
| CORNING INC |
| RECKITT BENCKISER GROUP PLC |
| ASTELLAS PHARMA INC |
| HEALTHPEAK PROPERTIES INC |
| SHIONOGI & CO LTD ORD |
| CVS HEALTH CORP |